A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults

Recruiting

Phase 3

VLA15A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults

Sponsor:

Pfizer

Code:

NCT07226882

Conditions

Lyme Borreliosis

Eligibility Criteria

Sex: All

Age: 18 - 44

Healthy Volunteers: Accepted

Interventions

VLA15

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-07. This information was provided to ClinicalTrials.gov by Pfizer on 2025-12-01.